assay
→
ReceivesAction
→
performed
|
0.82
|
|
assay
→
ReceivesAction
→
performed in triplicate
|
0.79
|
|
assay
→
ReceivesAction
→
repeated
|
0.71
|
|
assay
→
ReceivesAction
→
performed in duplicate
|
0.70
|
|
assay
→
ReceivesAction
→
validated
|
0.65
|
|
assay
→
ReceivesAction
→
evaluated
|
0.65
|
|
assay
→
ReceivesAction
→
completed
|
0.63
|
|
assay
→
HasProperty
→
sensitive
|
0.63
|
|
assay
→
ReceivesAction
→
developed
|
0.61
|
|
assay
→
ReceivesAction
→
run
|
0.59
|
|
assay
→
ReceivesAction
→
received
|
0.59
|
|
assay
→
ReceivesAction
→
performed in three independent experiments
|
0.58
|
|
assay
→
HasProperty
→
reproducible
|
0.58
|
|
assay
→
ReceivesAction
→
designed
|
0.58
|
|
assay
→
ReceivesAction
→
performed at 37°c
|
0.57
|
|
assay
→
ReceivesAction
→
performed in parallel
|
0.57
|
|
assay
→
ReceivesAction
→
performed in quadruplicate
|
0.56
|
|
assay
→
ReceivesAction
→
performed in a 96-well plate
|
0.56
|
|
assay
→
ReceivesAction
→
run in triplicate
|
0.54
|
|
assay
→
ReceivesAction
→
tested
|
0.52
|
|
assay
→
ReceivesAction
→
prepared
|
0.52
|
|
assay
→
CapableOf
→
employ quantitative sandwich enzyme immunoassay technique
|
0.50
|
|
assay
→
CapableOf
→
use primer
|
0.48
|
|
assay
→
ReceivesAction
→
performed at room temperature
|
0.48
|
|
assay
→
ReceivesAction
→
shown in table
|
0.48
|
|
assay
→
HasProperty
→
transferable
|
0.48
|
|
assay
→
HasA
→
high sensitivity
|
0.48
|
|
assay
→
CapableOf
→
use antibody
|
0.47
|
|
assay
→
HasA
→
excellent specificity
|
0.46
|
|
assay
→
CapableOf
→
prepare at the alaska assay laboratory
|
0.44
|
|
assay
→
ReceivesAction
→
performed in value
|
0.44
|
|
assay
→
ReceivesAction
→
employed
|
0.44
|
|
assay
→
ReceivesAction
→
described in detail
|
0.42
|
|
assay
→
HasProperty
→
automated
|
0.42
|
|
assay
→
CapableOf
→
employ a two-site sandwich
|
0.42
|
|
assay
→
CapableOf
→
use substrate
|
0.41
|
|
assay
→
ReceivesAction
→
used to characterize final cell product
|
0.41
|
|
assay
→
ReceivesAction
→
used to characterize the end-point assays
|
0.41
|
|
assay
→
ReceivesAction
→
carried out in 96 well microtitre plate
|
0.41
|
|
assay
→
ReceivesAction
→
described with 20 nm of enzyme solution
|
0.41
|
|
assay
→
HasProperty
→
simple
|
0.41
|
|
assay
→
ReceivesAction
→
described
|
0.39
|
|
assay
→
ReceivesAction
→
shown in figure
|
0.39
|
|
assay
→
HasProperty
→
laborious
|
0.39
|
|
assay
→
ReceivesAction
→
described in the materials
|
0.37
|
|
assay
→
ReceivesAction
→
known in the art
|
0.37
|
|
assay
→
CapableOf
→
employ competitive inhibition enzyme immunoassay technique
|
0.37
|
|
assay
→
ReceivesAction
→
described in methods
|
0.36
|
|
assay
→
ReceivesAction
→
initiated for calibration purposes
|
0.36
|
|
assay
→
HasProperty
→
helpful
|
0.36
|
|
assay
→
HasProperty
→
expensive
|
0.35
|
|
assay
→
CapableOf
→
use the polymerase chain reaction
|
0.35
|
|
assay
→
CapableOf
→
detect small deletions
|
0.35
|
|
assay
→
HasProperty
→
easy
|
0.35
|
|
assay
→
HasProperty
→
time-consuming
|
0.35
|
|
assay
→
HasProperty
→
low
|
0.34
|
|
assay
→
ReceivesAction
→
based on the hydrolysis of casein
|
0.34
|
|
assay
→
CapableOf
→
detect genomic dna
|
0.34
|
|
assay
→
ReceivesAction
→
extended
|
0.33
|
|
assay
→
CapableOf
→
flow cytometry
|
0.33
|
|
assay
→
CapableOf
→
measure hcg
|
0.33
|
|
assay
→
ReceivesAction
→
reported
|
0.33
|
|
assay
→
ReceivesAction
→
used in combination
|
0.32
|
|
assay
→
HasProperty
→
complex
|
0.32
|
|
assay
→
ReceivesAction
→
multiplexed
|
0.32
|
|
assay
→
ReceivesAction
→
incubated
|
0.32
|
|
assay
→
ReceivesAction
→
based on the principle
|
0.32
|
|
assay
→
ReceivesAction
→
illustrated in fig
|
0.32
|
|
assay
→
ReceivesAction
→
regarded
|
0.32
|
|
assay
→
ReceivesAction
→
performed at 25 °c
|
0.32
|
|
assay
→
ReceivesAction
→
incubated at 37°c
|
0.32
|
|
assay
→
HasProperty
→
adaptable
|
0.32
|
|
assay
→
HasProperty
→
critical
|
0.31
|
|
invention
→
RelatedTo
→
assay
|
0.31
|
|
assay
→
ReceivesAction
→
tested for specificity
|
0.31
|
|
assay
→
ReceivesAction
→
created
|
0.31
|
|
assay
→
CapableOf
→
detect amplified sequence
|
0.31
|
|
assay
→
ReceivesAction
→
performed in accordance
|
0.31
|
|
assay
→
ReceivesAction
→
performed by same experimenter
|
0.31
|
|
assay
→
ReceivesAction
→
conducted at three different temperatures
|
0.31
|
|
assay
→
CapableOf
→
detect blood changes
|
0.31
|
|
assay
→
CapableOf
→
detect point mutations
|
0.31
|
|
assay
→
CapableOf
→
detect small insertions
|
0.31
|
|
assay
→
ReceivesAction
→
performed on analyzer
|
0.29
|
|
assay
→
ReceivesAction
→
performed on bone marrow
|
0.29
|
|
assay
→
ReceivesAction
→
released
|
0.29
|
|
assay
→
ReceivesAction
→
performed with 6 replicates
|
0.29
|
|
assay
→
ReceivesAction
→
performed with error bars
|
0.29
|
|
assay
→
ReceivesAction
→
read
|
0.29
|
|
assay
→
ReceivesAction
→
described in the legend
|
0.29
|
|
assay
→
ReceivesAction
→
printed
|
0.29
|
|
assay
→
HasProperty
→
amenable
|
0.29
|
|
assay
→
CapableOf
→
provide information
|
0.27
|
|
assay
→
ReceivesAction
→
performed using our existing methodology
|
0.27
|
|
assay
→
ReceivesAction
→
performed with appropriate assay controls
|
0.27
|
|
assay
→
ReceivesAction
→
replicated
|
0.27
|
|
assay
→
ReceivesAction
→
based on the observation
|
0.27
|
|
assay
→
ReceivesAction
→
employed in the phenotyping platforms
|
0.27
|
|
assay
→
ReceivesAction
→
utilized in preferred embodiment
|
0.27
|
|
assay
→
ReceivesAction
→
completed at independent laboratories
|
0.27
|
|
assay
→
ReceivesAction
→
performed by icp methods
|
0.27
|
|
assay
→
ReceivesAction
→
qualified
|
0.27
|
|
assay
→
ReceivesAction
→
developed with anti-mouse igg antibody
|
0.27
|
|
assay
→
CapableOf
→
consist of two modules
|
0.27
|
|
assay
→
ReceivesAction
→
shown in peer-reviewed published studies
|
0.27
|
|
assay
→
CapableOf
→
quantify pd-l1 transcript levels
|
0.27
|
|
assay
→
HasProperty
→
invasive
|
0.27
|
|
assay
→
ReceivesAction
→
conducted with transfected cell membranes
|
0.27
|
|
assay
→
CapableOf
→
determine n-sulfated glycosaminoglycan ratio
|
0.27
|
|
assay
→
ReceivesAction
→
conducted for each cell line
|
0.27
|
|
assay
→
ReceivesAction
→
adapted to 1536
|
0.27
|
|
assay
→
ReceivesAction
→
adapted to other formats
|
0.27
|
|
assay
→
HasProperty
→
cost-effective
|
0.27
|
|
assay
→
CapableOf
→
help enabling mass spectrometry
|
0.26
|
|
assay
→
ReceivesAction
→
used in the future
|
0.25
|
|
assay
→
HasProperty
→
high
|
0.25
|
|
assay
→
ReceivesAction
→
required to verify fineness
|
0.25
|
|
assay
→
CapableOf
→
exceed 10,000 parts per million
|
0.25
|
|
assay
→
CapableOf
→
utilize non-radioactive assay endpoint
|
0.25
|
|
assay
→
ReceivesAction
→
initiated
|
0.25
|
|
assay
→
CapableOf
→
report on quaternary structure
|
0.25
|
|
assay
→
ReceivesAction
→
performed at ph
|
0.25
|
|
assay
→
ReceivesAction
→
carried out in 4 donors
|
0.25
|
|
assay
→
SimilarTo
→
in figure
|
0.25
|
|
assay
→
HasA
→
91% specificity
|
0.25
|
|
assay
→
CapableOf
→
ended in research
|
0.25
|
|
assay
→
CapableOf
→
ensure label accuracy
|
0.25
|
|
assay
→
CapableOf
→
ensure overall quality
|
0.25
|
|
assay
→
CapableOf
→
use whole blood
|
0.25
|
|
assay
→
ReceivesAction
→
run against multi-drug resistant bacterial species
|
0.25
|
|
assay
→
ReceivesAction
→
performed on blood
|
0.25
|
|
assay
→
HasProperty
→
coulometric
|
0.25
|
|
assay
→
HasProperty
→
amperometric
|
0.25
|
|
assay
→
HasProperty
→
potentiometric
|
0.25
|
|
assay
→
CapableOf
→
miss or all existing drug-resistance mutations
|
0.25
|
|
assay
→
ReceivesAction
→
used to guide treatment
|
0.25
|
|
assay
→
CapableOf
→
show rare earths
|
0.25
|
|
assay
→
CapableOf
→
detect gene fusions
|
0.25
|
|
assay
→
CapableOf
→
use the two-plate assay protocol
|
0.25
|
|
assay
→
CapableOf
→
use mtt
|
0.25
|
|
assay
→
CapableOf
→
use xtt
|
0.25
|
|
assay
→
CapableOf
→
use mts
|
0.25
|
|
assay
→
CapableOf
→
use wst-1
|
0.25
|
|
assay
→
ReceivesAction
→
linked
|
0.25
|
|
assay
→
ReceivesAction
→
performed at 4°c
|
0.25
|
|
assay
→
ReceivesAction
→
run on most automated biochemistry analysers
|
0.25
|
|
assay
→
ReceivesAction
→
used to assay for effect
|
0.25
|
|
assay
→
ReceivesAction
→
performed on duplicate samples
|
0.25
|
|
assay
→
ReceivesAction
→
used as gold standard
|
0.25
|
|
assay
→
CapableOf
→
provide datum
|
0.25
|
|
assay
→
CapableOf
→
discriminate
|
0.25
|
|
assay
→
ReceivesAction
→
carried out for quadruplicate transfection experiments
|
0.25
|
|
assay
→
CapableOf
→
measure antigen-specific t cell responses
|
0.25
|
|
assay
→
ReceivesAction
→
performed on small volumes of whole blood
|
0.25
|
|
assay
→
CapableOf
→
remain accurate
|
0.25
|
|
assay
→
CapableOf
→
involve mixing sample
|
0.25
|
|
assay
→
ReceivesAction
→
conducted in the presence of fixed adomet
|
0.25
|
|
assay
→
ReceivesAction
→
conducted in the presence of fixed bfc
|
0.25
|
|
assay
→
ReceivesAction
→
followed by western blotting
|
0.25
|
|
assay
→
ReceivesAction
→
carried out in representative
|
0.25
|
|
assay
→
CapableOf
→
focus on specific diseases
|
0.25
|
|
assay
→
ReceivesAction
→
performed on fully-automated bd max™ system
|
0.25
|
|
assay
→
CapableOf
→
detect signs of the disease
|
0.25
|
|
assay
→
CapableOf
→
screen drug
|
0.25
|
|
assay
→
ReceivesAction
→
performed in two independent experiments
|
0.25
|
|
assay
→
ReceivesAction
→
expressed in terms of central tendency
|
0.25
|
|
assay
→
ReceivesAction
→
substituted
|
0.25
|
|
assay
→
CapableOf
→
measure cytotoxicity
|
0.25
|
|
assay
→
ReceivesAction
→
aligned in a plurality of grooves
|
0.25
|
|
assay
→
ReceivesAction
→
run at standard conditions
|
0.25
|
|
assay
→
AtLocation
→
micrograms per gram of hair
|
0.25
|
|
assay
→
ReceivesAction
→
performed in tube
|
0.25
|
|
assay
→
ReceivesAction
→
described in ref.31
|
0.25
|
|
assay
→
ReceivesAction
→
performed at the effector
|
0.25
|
|
assay
→
ReceivesAction
→
intended for forensic use
|
0.25
|
|
assay
→
HasProperty
→
generic
|
0.25
|
|
assay
→
ReceivesAction
→
difficult to perform
|
0.25
|
|
assay
→
HasProperty
→
unreliable
|
0.24
|
|
assay
→
HasProperty
→
more accurate
|
0.22
|
|
assay
→
HasProperty
→
faster
|
0.22
|
|
assay
→
HasProperty
→
cumbersome
|
0.19
|
|
assay
→
HasProperty
→
successful
|
0.19
|
|
assay
→
HasProperty
→
excellent
|
0.19
|
|
assay
→
CapableOf
→
ensure the highest assay sensitivity
|
0.19
|
|
assay
→
ReceivesAction
→
miniaturized
|
0.19
|
|
assay
→
ReceivesAction
→
excluded
|
0.19
|
|
assay
→
HasProperty
→
less expensive
|
0.16
|
|
assay
→
ReceivesAction
→
performed in convenient 96-well
|
0.16
|
|
assay
→
ReceivesAction
→
performed in 384
|
0.16
|
|
assay
→
CapableOf
→
interrogate other regulatory elements
|
0.16
|
|
assay
→
HasProperty
→
slow
|
0.16
|
|
assay
→
CapableOf
→
detect the presence of the virus
|
0.16
|
|
assay
→
HasProperty
→
old
|
0.16
|
|
assay
→
ReceivesAction
→
engineered
|
0.16
|
|
assay
→
HasProperty
→
perfect
|
0.16
|
|
assay
→
HasPrerequisite
→
two reagents
|
0.16
|
|
assay
→
HasA
→
a detection limit
|
0.16
|
|
assay
→
UsedFor
→
live-cell imaging
|
0.16
|
|
assay
→
HasProperty
→
attractive
|
0.16
|
|
assay
→
CapableOf
→
detect small changes
|
0.16
|
|
assay
→
CapableOf
→
reverse the effects of repeat expansion
|
0.16
|
|
assay
→
ReceivesAction
→
performed in vitro
|
0.09
|
|